We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSPQ.WS
13126
DELISTED
TCW Special Purpose Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TSPQ.WS
$64K ﹤0.01%
+103,808
New +$82.2K
CALA
13127
PUT
DELISTED
Calithera Biosciences, Inc
CALA
$64K ﹤0.01%
1,475
+475
+48% +$20.5K
NFH.WS
13128
DELISTED
New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
NFH.WS
$64K ﹤0.01%
21,718
-2,078
-9% -$6.08K
HUDI icon
13129
Huadi International Group
HUDI
$13.7M
$63K ﹤0.01%
14,455
-11,511
-44% -$49.5K
REFR icon
13130
CALL
Research Frontiers
REFR
$15.3M
$63K ﹤0.01%
24,500
+400
+2% +$924
SIFY
13131
CALL
Sify Technologies
SIFY
$1.13B
$63K ﹤0.01%
3,117
-150
-5% -$3.1K
ZKIN icon
13132
PUT
ZK International Group
ZKIN
$60.8M
$63K ﹤0.01%
3,214
-4,943
-61% -$117K
CUEN
13133
DELISTED
Cuentas Inc. Common Stock
CUEN
$63K ﹤0.01%
+1,677
New +$75.7K
AKTX
13134
Akari Therapeutics
AKTX
$13.2M
$62K ﹤0.01%
47
-18
-28% -$24.5K
ASC icon
13135
CALL
Ardmore Shipping
ASC
$719M
$62K ﹤0.01%
14,900
+3,700
+33% +$13.1K
DPRO
13136
Draganfly
DPRO
$180M
$62K ﹤0.01%
+742
New +$62.7K
SGLY icon
13137
CALL
Singularity Future Technology
SGLY
$4.41M
$62K ﹤0.01%
194
+40
+26% +$15.7K
TALK icon
13138
PUT
Talkspace
TALK
$871M
$62K ﹤0.01%
+16,900
New +$92.8K
NEPT
13139
CALL
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$62K ﹤0.01%
74
+10
+16% +$10.6K
STSA
13140
PUT
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$62K ﹤0.01%
+13,300
New +$70.5K
HBP
13141
PUT
DELISTED
Huttig Building Products, Inc.
HBP
$62K ﹤0.01%
11,600
-8,700
-43% -$49.5K
VOLT
13142
PUT
DELISTED
Volt Information Sciences, Inc.
VOLT
$62K ﹤0.01%
17,600
-16,300
-48% -$71K
PLM
13143
DELISTED
PolyMet Mining Corp.
PLM
$62K ﹤0.01%
20,189
-17,364
-46% -$57.9K
ASMB icon
13144
PUT
Assembly Biosciences
ASMB
$653M
$61K ﹤0.01%
1,467
-1,933
-57% -$81K
AXDX
13145
CALL
DELISTED
Accelerate Diagnostics
AXDX
$61K ﹤0.01%
1,040
+10
+1% +$652
BCDA icon
13146
BioCardia
BCDA
$14.5M
$61K ﹤0.01%
1,286
-806
-39% -$39.5K
ZSTK
13147
ZeroStack Corp
ZSTK
$22.4M
$61K ﹤0.01%
+14
New +$81.7K
LPCN icon
13148
Lipocine
LPCN
$17.4M
$61K ﹤0.01%
+3,272
New +$72.2K
NTBL
13149
PUT
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$61K ﹤0.01%
849
+43
+5% +$3.35K
SEAC
13150
PUT
DELISTED
Seachange International Inc
SEAC
$61K ﹤0.01%
2,865
+1,805
+170% +$38.7K

Similar funds

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.